INTERNATIONAL PATENT: SECARNA PHARMACEUTICALS GMBH & CO. KG FILES APPLICATION FOR "NRP1-SPECIFIC ANTISENSE OLIGONUCLEOTIDES WITH REDUCED OFF-TARGET BINDING FOR USE IN PREVENTING AND/OR TREATING CANCER"

GENEVA, May 4 -- SECARNA PHARMACEUTICALS GMBH & CO. KG (Rudolf-Bultmann-Str. 4h35039 Marburg) filed a patent application (PCT/EP2025/080381) for "NRP1-SPECIFIC ANTISENSE OLIGONUCLEOTIDES WITH REDUCED OFF-TARGET BINDING FOR USE IN PREVENTING AND/OR TREATING CANCER" on Oct 21, 2025. With publication no. WO/2026/087533, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SADEWASSER, Anne (c/o Rudolf-Bultmann-Str. 4h35039 Marburg), MICHEL, Sven (c/o Rudolf-Bultmann-Str. 4h35039 Marburg), MAASKE, Andre (c/o Rudolf-Bultmann-Str. 4h...